The current and future faces of stereotactic body radiation therapy for thoracic malignancies

The field of radiation oncology has undergone a shift in practice towards hypofractionation, a movement that has seen increasing momentum over the past decade. This trend responds in part to a need that has been identified throughout oncology for maximally effective and efficient allocation of resources, cost containment, and further side effect mitigation. Specific to the field of radiation oncology, hypofractionation also plays an integral role in dose escalation and improved tumor control.